ergomed
EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients
April 2, 2020Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab
EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …
EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications
March 31, 2020Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma
Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
Former Ergomed CEO appointed as Midatech’s Chief Financial Officer
September 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ergomed, midatech
Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect. He will be …
Ergomed announces board changes
January 19, 2016Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance
Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …
Ergomed strengthens management team and board
July 15, 2015Research and Development, Sales and Marketing Andrew Mackie, ergomed
UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …
Clinigen chief executive joins Ergomed board
May 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, ergomed, george
UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

 George has over 20 …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
